While I believe Pfizer will rebound eventually, it will take some time to do so, and it may not occur in 2026. In the ...

There were 1,399 unusually active options in Thursday’s trading. Pfizer’s March 20 $29 put had the highest Vol/OI ratio at ...

As of Friday, January 09, Allogene Therapeutics, Inc.’s ALLO share price has surged by 18.13%, which has investors ...

Bristol Myers Squibb Company BMY has delivered a solid performance in recent months. The biotech major’s shares have gained ...

Donald Trump announced a drug deal with Pfizer in the Oval Office several months ago in September. During Q&A with the press, Trump bragged about being a "better" person. "I have a bigger heart than ...

Dow Jones Industrial Average, Chevron Corp, Coca-Cola Co, Merck & Company Inc. Read 's Market Analysis on Investing.com ...

Madrigal Pharmaceuticals (MDGL) stock is in focus as the company licenses Pfizer’s (PFE) experimental MASH therapy ervogastat. Read more here.

Meanwhile, another $70 million to $80 million of IPO proceeds is expected to fund the launch a phase 1b study of its second ...

Royalty Pharma plc (Nasdaq: RPRX) today announced that its board of directors has declared a dividend for the first quarter of 2026 of $0.235 per Class A ordinary share, reflecting a 6.8% increase in ...

In 2025 alone, MSD acquired infectious disease specialist Cidara Therapeutics for $9.2 billion, respiratory drug developer ...

Daily Journal (DJCO) is trading at new a 52-week high and has strong technical momentum. ・Shares are up nearly 25% in the ...

With a lioness-themed rebrand tied to its latest buy, Athira Pharma is roaring into the new year under its second new moniker.  | The LeonaBio rebrand comes from the name Leona, which means lioness ...